Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Epigenetics (R)evolution

Mar 01 2009

• By Ellen Licking

Related Content

Alnylam Takes Platform Monetization to a Whole New and Non-Exclusive Level

Jul 01 2007

Sirtris Satisfies GSK's M&A Appetite

May 01 2008

Related Companies

Novartis AG

OSI Systems, Inc.

Massachusetts Institute of Technology

Epizyme, Inc.

Constellation Pharmaceuticals, Inc.

Sirna Therapeutics

Alnylam Pharmaceuticals Inc.

Merck & Co., Inc.

Dicerna Pharmaceuticals, Inc.

Silence Therapeutics plc

AstraZeneca PLC

Sirtris Pharmaceuticals

GSK plc

Bristol Myers Squibb Company

Eisai Co., Ltd.

Chroma Therapeutics Limited

Repligen Corp.

Mirati Therapeutics, Inc.

Johnson & Johnson

Pfizer Inc.

Harvard University

New York University School of Medicine

Rockefeller University

National Institutes of Health

National Cancer Institute

Takeda Pharmaceutical Co. Ltd.

University of North Carolina at Chapel Hill

Additional Topics

Business Strategies Innovation Legal Issues Platform Technologies BioPharmaceutical

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window